3,4-dehydroproline has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hacker, MP; Hong, CB; Newman, RA | 1 |
| Herriott, MJ; Leu, RW; Shannon, BJ; Zhou, AQ | 1 |
2 other study(ies) available for 3,4-dehydroproline and Experimental Neoplasms
| Article | Year |
|---|---|
The effect of L-3, 4-dehydroproline on the antitumor activity and toxicity of bleomycin.
Topics: Animals; Bleomycin; Body Weight; Drug Interactions; Male; Melanoma; Mice; Neoplasms, Experimental; Proline; Rats; Rats, Inbred Strains | 1983 |
Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
Topics: 2,2'-Dipyridyl; Animals; Antibody-Dependent Cell Cytotoxicity; Complement C1q; Cytotoxicity, Immunologic; In Vitro Techniques; Interferon-gamma; Lipid A; Macrophage Activation; Macrophages; Mice; Neoplasms, Experimental; Proline; Pyridines; Secretory Rate | 1990 |